tagraxofusp
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
tagraxofusp
Jun 7, 2024, 00:51 |
Blog
BPDCN treatment and management CD123-targeting agents the Video Journal of Hematology and Hematological Oncology podcast covers
Video Journal of Hematology and Hematological Oncology shared on their LinkedIn: ''NEW podcast episode: BPDCN…
Apr 21, 2024, 21:27 |
Drugs
Hagop Kantarjian: We review the evidence leading to Tagraxofusp approval as first in class CD123-directed drug which has changed the field of BPDCN
Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X: “Tazgraxofusp is…
Apr 19, 2024, 20:20 |
Drugs
This new review article is all about Tagraxofusp for BPDCN - ACS Journal Cancer
ACS Journal Cancer recently shared on X: "This new review article from Wei Ying Jen,…
Feb 26, 2024, 19:07 |
Blog
Naveen Pemmaraju: Our brand new paper just out in L and L
Naveen Pemmaraju posted on X/Twitter: “Delighted to share our brand new paper just out in…
All:
4
Posts:
1 - 100
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 7
ESTRO: Everything You Need to Know About European Society for Radiotherapy and Oncology
Jane Fonda Breast Cancer and Non-Hodgkin Lymphoma: How She Went Against, How She Survived, and More
Inside OncoDaily Party Barcelona
Zainab Shinkafi-Bagudu has been elected as UICC President-Elect 2024-2026
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube